Holen Sie sich die Stockscreener-App
302.61
0.56%
-1.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$303.93
Offen:
$303.99
24-Stunden-Volumen:
92,242
Relative Volume:
0.11
Marktkapitalisierung:
$21.39B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
40.45
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
-0.05%
1M Leistung:
+8.72%
6M Leistung:
+17.25%
1J Leistung:
+40.29%
1-Tages-Spanne:
$299.72
$305.51
1-Wochen-Bereich:
$295.90
$309.03
52-Wochen-Spanne:
$203.74
$330.88
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
302.81 | 21.51B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
445.61 | 155.80B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.10 | 39.22B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.53 | 32.17B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.11 | 30.46B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
210.27 | 29.61B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Here's what to expect from West Pharmaceutical's next earnings report - MSN
Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report - Benzinga
West Pharma drops after cyber attack - MSN
S&P 500 gains and losses today: West Pharmaceutical Services stock surges; Dow, LKQ shares fall - MSN
West Declares Quarterly Dividend - Quantisnow
Ransomware Attacks on West Pharmaceutical and Foxconn Highlight Growing Cyber Risks to Manufacturing Sector - Homeland Security Today
Zacks Research Analysts Raise Earnings Estimates for WST - MarketBeat
West Pharmaceutical (WST) Provides Cyberattack Recovery Update - GuruFocus
West Pharmaceutical Services ramps production following cyberattack - Investing.com
West Pharmaceutical says making progress in restoring global operations after cyberattack - marketscreener.com
West Pharma says operations recovering after cyberattack - WSAU
West Pharmaceutical Services ramps production following cyberattack By Investing.com - Investing.com Canada
Apprenticeship Week highlights ‘earn-while-you-learn’ approach - The Pennsylvania State University
West Pharmaceutical Services Inc announced that its High Value Product (HVP) sites, standard packaging sites, and HVP delivery device sites have now fully resumed shipping and receiving operations. - Bitget
West Pharmaceutical Services Inc recently announced that the company has continued to make significant progress in restoring operations after responding to a global cyberattack incident. - Bitget
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - TradingView
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care - TradingView
Coated Butyl Rubber Stopper Market is Expanding Globally | Major - openPR.com
West Pharmaceutical Services (NYSE:WST) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Cyberattack On West Pharmaceutical Halts Manufacturing Across Multiple Sites - Information Security Buzz
West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions - Sahm
[Form 4] WEST PHARMACEUTICAL SERVICES INC Insider Trading Activity - Stock Titan
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay - TradingView
Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA) - The Globe and Mail
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down - TradingView
West Pharmaceutical starts restoring operations after ransomware attack - Cybersecurity Dive
Expert Insights on the West Pharmaceutical Ransomware Attack - Security Magazine
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Ransomware attacks on West Pharmaceutical and Foxconn highlight growing cyber risks to manufacturing sector - Industrial Cyber
West Pharmaceutical stock (US9523901012): Ransomware attack disrupts operations - AD HOC NEWS
West Pharmaceutical Services (WST) Reports Material Cybersecurit - GuruFocus
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical says hackers stole data, encrypted systems - BleepingComputer
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Pharmaceutical Services Hit by Disruptive Ransomware Attack - Security Boulevard
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating - Moomoo
West Pharmaceutical stock (US9523901012): Ransomware attack disrupts manufacturing - AD HOC NEWS
West Pharmaceutical stock (US9523901012): Cybersecurity attack triggers 3.6% drop - AD HOC NEWS
A Look at West Pharmaceutical Services Inc (WST) After 4.2% Decl - GuruFocus
Does West Pharmaceutical’s Rejected Independent Chair Proposal Reflect a Stable Governance Edge for WST? - Yahoo Finance
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Faces Operational Disruption Due to Cyber Incident - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
West Pharma (WST) Faces Cybersecurity Attack, Stock Drops 3.6% - GuruFocus
Investors Await Damage Assessment After West Pharmaceutical Cyberattack - Benzinga
West Pharma drops after cyber attack (WST:NYSE) - Seeking Alpha
West Pharmaceutical stock (US9523901012): Material cyberattack disrupts global operations - AD HOC NEWS
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
West Pharmaceutical Says Recent Cybersecurity Attack Temporarily Disrupted Operations - Moomoo
West Pharmaceutical Services reports cybersecurity incident affecting operations By Investing.com - Investing.com South Africa
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):